Ironwood Pharmaceuticals appoints Tammi Gaskins as chief executive officer

IRWD•2026-10-16

Ironwood Pharmaceuticals appointed Tammi Gaskins as CEO effective January 1, 2027. Tom McCourt will retire as CEO that day and remain on the board.

1. CEO transition

Ironwood Pharmaceuticals said Tammi Gaskins will become chief executive officer effective January 1, 2027. Tom McCourt will retire as CEO on that date and remain on the board.

Ironwood Pharmaceuticals appoints Tammi Gaskins as chief executive officer

1. CEO transition

Related News

OPKO Health raised to outperform from market perform by Barrington Research

Marqeta expands Coinbase partnership to offer stablecoin-backed cards

Atlanta Braves Holdings publishes update to financial calendar

Baytex Energy Corp.: BMO raises target price to C$8 from C$7

Verastem raises target price to $14 from $13